General MedicationsORALGeneric
RISPERDAL
RISPERIDONE
Standard Dose
5MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary
Approval overview RISPERDAL is listed in Drugs@FDA under application 020272 (NDA).
Review priority: STANDARD Marketing status: Discontinued Active ingredient RISPERIDONE Form and strength TABLET;ORAL - 5MG Sponsor JANSSEN PHARMS Submission history Latest submission status date: 2025-01-22 00:00:00.
Structured Monograph
Clinical summary
Approval overview RISPERDAL is listed in Drugs@FDA under application 020272 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient RISPERIDONE Form and strength TABLET;ORAL - 5MG Sponsor JANSSEN PHARMS Submission history Latest submission status date: 2025-01-22 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Discontinued
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.